Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2176772 Target Snapshot

E3 ubiquitin-protein ligase TRIM33 · SINGLE PROTEIN · Homo sapiens

157Compounds
47Assays
0Approved Drugs
137.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9UPN9. Use UniProt Q9UPN9 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9UPN9 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats E3 ubiquitin-protein ligase TRIM33 as ChEMBL target CHEMBL2176772, mapped to UniProt Q9UPN9. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
E3 ubiquitin-protein ligase TRIM33
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2176772
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9UPN9
E3 ubiquitin-protein ligase TRIM33
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether E3 ubiquitin-protein ligase TRIM33 is the right protein anchor across sources, using UniProt Q9UPN9 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelE3 ubiquitin-protein ligase TRIM33
UniProt AccessionQ9UPN9
Component TypeProtein
Sequence Length1127 aa

E3 ubiquitin-protein ligase TRIM33

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as E3 ubiquitin-protein ligase TRIM33, mapped to UniProt Q9UPN9. Sequence length is 1127 aa.

Mapped IDQ9UPN9
Review nameE3 ubiquitin-protein ligase TRIM33
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Phase II
Assay Mix

Activity Type Distribution

IC50121.0
KD16.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4440737 8.5 IC50 3.19 Preclinical
CHEMBL4470967 7.86 IC50 13.72 Preclinical
CHEMBL1232461 6.85 IC50 140.0 Clinical
CHEMBL1232461 6.76 Kd 173.0 Clinical
CHEMBL18620 6.63 IC50 233.5 Preclinical
CHEMBL4467793 6.62 IC50 240.3 Preclinical
CHEMBL18737 6.6 IC50 249.8 Preclinical
CHEMBL4572394 6.57 IC50 268.9 Preclinical
CHEMBL543846 6.55 IC50 283.4 Preclinical
CHEMBL108925 6.52 IC50 299.4 Preclinical
Distribution

pChEMBL Value Distribution

15
5.0
7
5.5
5
6.0
11
6.5
0
7.0
1
7.5
0
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

47
Total Assays
117
Tested Compounds
1
Assay Types
Binding — 47 assays, 117 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 23 117 5.1
assay format 19 0
cell-based format 5 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine